StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of NASDAQ:SRNE opened at $0.01 on Monday. The business’s 50-day moving average is $0.02 and its 200-day moving average is $0.05. […]
Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
DelveInsight Business Research, LLP: Malignant Ascites Market to Observe Growth at a CAGR of 1.2% by 2034 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of SRNE stock opened at $0.02 on Friday. The firm’s 50 day moving average price is $0.02 and its two-hundred […]